Examples of using Package leaflets in English and their translations into Portuguese
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Official/political
Information on the label and package leaflets;
See also the package leaflets for peginterferon alfa and ribavirin.
About these medicines is described in separate package leaflets.
C Studies on the readability of the package leaflets of other products than medications.
Original package leaflets+ 3 optimized package leaflets shorter phrases, simple text.
To review studies on the readability of package leaflets of medicinal products for human use.
Read the package leaflets for these other medicines for information regarding driving and using machines.
Furthermore, it is important that you carefully read the package leaflets that are provided with these medicines.
Labelling and package leaflets;(ii) classification for supply;(iii) wholesale distribution.
Thumbnail Table 1 Inclusion andexclusion criteria of studies on the package leaflets of medicinal products for human use.
You must read the package leaflets for peginterferon alfa and ribavirin for additional information.
You still need to follow the instructions given in the package leaflets for the other medicines you are taking.
Read the package leaflets for these medicines for their dosage and directions on‘how to take' them.
If you are unsure of any information in the package leaflets, please contact your doctor or pharmacist.
Please read the package leaflets for the individual medicines you are given for further information on these medicines.
The objective of the present study was to review studies on the readability of package leaflets of medicinal products for human use.
Therefore carefully read the Package Leaflets of ritonavir and your child's other antiretroviral medicines.
In addition the applicant shall provide samples or mock-ups of the packaging,labels and package leaflets for the medicinal product concerned.
It would seem important here for the package leaflets to be heeded and for there to be a compulsory text on product use.
As Ongentys will be used with other levodopa medicines,please also read the package leaflets of these medicines carefully.
See also the package leaflets for peginterferon alfa and ribavirin for side effects reported for these products.
Overall, the application of the descriptive methodologies confirmed a low readability of the package leaflets and the need to simplify the texts.
Therefore carefully read the Package Leaflets of ritonavir and your other antiretroviral.
For further information on VFEND 50 mg and 200 mg film-coated tablets or VFEND 200 mg powder for solution for infusion,please see the User Package Leaflets for these products.
EURORDIS experts review primarily package leaflets and EPAR summaries for orphan medicines.
Medicine package leaflets and EPARs provide crucial information to help patients use their medicine correctly and safely.
Reminder: Please also read the“Pregnancy and breast-feeding” section of the Package Leaflets for peginterferon alfa and ribavirin before you start taking Victrelis.
The absence of warnings on package leaflets and the sale of these drugs without a prescription makes the problem worse, and fosters exposure of elderly patients to these PIMs.
You should therefore carefully read the Package Leaflets of ritonavir and your other antiretroviral medicines.
Please also read the package leaflets for the other medicines(‘chemotherapy') that are part of your treatment, to see if they are suitable for you.